Li X - Search Results

1

An artificial intelligence network-guided signature for predicting outcome and immunotherapy response in lung adenocarcinoma patients based on 26 machine learning algorithms.

Zhang N, Zhang H, Liu Z, Dai Z, Wu W, Zhou R, Li S, Wang Z, Liang X, Wen J, Zhang X, Zhang B, Ouyang S, Zhang J, Luo P, Li X, Cheng Q. Zhang N, et al. Among authors: li s, li x. Cell Prolif. 2023 Apr;56(4):e13409. doi: 10.1111/cpr.13409. Epub 2023 Feb 23. Cell Prolif. 2023. PMID: 36822595 Free PMC article.

2

CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas.

Xu S, Li X, Tang L, Liu Z, Yang K, Cheng Q. Xu S, et al. Among authors: li x. Front Mol Biosci. 2021 Sep 1;8:706949. doi: 10.3389/fmolb.2021.706949. eCollection 2021. Front Mol Biosci. 2021. PMID: 34540893 Free PMC article.

3

The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma.

Li X, Dai Z, Wu X, Zhang N, Zhang H, Wang Z, Zhang X, Liang X, Luo P, Zhang J, Liu Z, Zhou Y, Cheng Q, Chang R. Li X, et al. Front Immunol. 2022 Apr 22;13:749241. doi: 10.3389/fimmu.2022.749241. eCollection 2022. Front Immunol. 2022. PMID: 35529878 Free PMC article.

4

Cuproptosis Depicts Immunophenotype and Predicts Immunotherapy Response in Lung Adenocarcinoma.

Zhou W, Cheng Y, Li L, Zhang H, Li X, Chang R, Xiao X, Lu L, Yi B, Gao Y, Zhang C, Zhang J. Zhou W, et al. Among authors: li x, li l. J Pers Med. 2023 Mar 8;13(3):482. doi: 10.3390/jpm13030482. J Pers Med. 2023. PMID: 36983664 Free PMC article.

5

MICAL2 is a novel nucleocytoplasmic shuttling protein promoting cancer invasion and growth of lung adenocarcinoma.

Zhou W, Liu Y, Gao Y, Cheng Y, Chang R, Li X, Zhou Y, Wang S, Liang L, Duan C, Zhang C. Zhou W, et al. Among authors: li x. Cancer Lett. 2020 Jul 28;483:75-86. doi: 10.1016/j.canlet.2020.04.019. Epub 2020 Apr 28. Cancer Lett. 2020. PMID: 32360180

6

Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction.

Li L, Cai Q, Wu Z, Li X, Zhou W, Lu L, Yi B, Chang R, Zhang H, Cheng Y, Zhang C, Zhang J. Li L, et al. Among authors: li x. Sci Rep. 2023 Feb 11;13(1):2455. doi: 10.1038/s41598-023-29684-9. Sci Rep. 2023. PMID: 36774446 Free PMC article.

7

CHIP-mediated CIB1 ubiquitination regulated epithelial-mesenchymal transition and tumor metastasis in lung adenocarcinoma.

Liu Y, Zhou Y, Zhang P, Li X, Duan C, Zhang C. Liu Y, et al. Among authors: li x. Cell Death Differ. 2021 Mar;28(3):1026-1040. doi: 10.1038/s41418-020-00635-5. Epub 2020 Oct 20. Cell Death Differ. 2021. PMID: 33082516 Free PMC article.

8

XBP1- IGFBP3 Signaling Pathway Promotes NSCLC Invasion and Metastasis.

Luo Q, Shi W, Dou B, Wang J, Peng W, Liu X, Zhao D, Tang F, Wu Y, Li X, Li J, Wen S, Zhang C, Duan C. Luo Q, et al. Among authors: li j, li x. Front Oncol. 2021 May 18;11:654995. doi: 10.3389/fonc.2021.654995. eCollection 2021. Front Oncol. 2021. PMID: 34094948 Free PMC article.

9

tRNA-derived small RNAs: novel regulators of cancer hallmarks and targets of clinical application.

Li X, Liu X, Zhao D, Cui W, Wu Y, Zhang C, Duan C. Li X, et al. Cell Death Discov. 2021 Sep 18;7(1):249. doi: 10.1038/s41420-021-00647-1. Cell Death Discov. 2021. PMID: 34537813 Free PMC article. Review.

10

Integrative bioinformatic analysis identified IFIT3 as a novel regulatory factor in psoriasis.

Li X, Zhou W, Wang D. Li X, et al. J Cell Biochem. 2022 Dec;123(12):2066-2078. doi: 10.1002/jcb.30332. Epub 2022 Sep 28. J Cell Biochem. 2022. PMID: 36169003

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180,856 results

Search Page

Filters